The Federal Anti-Nepotism Law, and More from CRS
The “disruptive” character of the Trump transition is already keeping the analysts and lawyers at the Congressional Research Service busy.
One new CRS analysis responds to the question of whether the employment of Trump family members in the transition or the Administration would violate the federal law against nepotism, which generally prohibits the hiring of relatives to government jobs. The answer is not crystal clear, for several reasons explained in the new analysis. It may be that an otherwise prohibited appointment would be permitted, for example, if the appointee forgoes compensation. See The Federal Anti-Nepotism Statute: Limits on Appointing, Hiring, and Promoting Relatives, CRS Legal Sidebar, December 1, 2016.
Could President Trump simply withdraw the United States from the international Paris Agreement on climate change? Again, the answer is murky. “Historical practice would appear to suggest that, because the Paris Agreement is an executive agreement, domestic law would allow the President to unilaterally withdraw from the Agreement without approval from the legislative branch.” On the other hand, maybe not. See Can the President Withdraw from the Paris Agreement?, CRS Legal Sidebar, December 5, 2016.
Another CRS brief examines the waiver that would be needed if General (ret.) James Mattis were to serve as Secretary of Defense, a departure from the normal principle of civilian control of the military. “CRS has been able to identify [only] one instance of Congress acting to waive this provision,” namely in response to President Truman’s 1950 nomination of Gen. George C. Marshall to be Secretary of Defense. See Waiver of Statutory Qualifications Relating to Prior Military Service of the Secretary of Defense, CRS Insight, December 1, 2016.
Other new and updated reports from the Congressional Research Service include the following.
European Union Efforts to Counter Disinformation, CRS Insight, December 1, 2016
Fidel Castro’s Death: Implications for Cuba and U.S. Policy, CRS Insight, December 2, 2016
Iran Nuclear Agreement, updated December 5, 2016
Internet Sales and State Taxes: Policy Issues, CRS Insight, December 1, 2016
Social Security Primer, updated December 5, 2016
An Introduction to Judicial Review of Federal Agency Action, December 5, 2016
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.